Effects of anti-β2-glycoprotein i antibody on PlGF, VEGF and sVEGFR1 production from cultured choriocarcinoma cell line

Journal of Obstetrics and Gynaecology Research

Volumn 37, Issue 8, 2011, Pages 1076-1083

  Ichikawa, Go ^a   Yamamoto, Tatsuo ^a   Chishima, Fumihisa ^a   Nakamura, Akikazu ^a   Kuno, Souichirou ^a   Murase, Takayuki ^a   Suzuki, Manami ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti 2 glycoprotein I antibody; Choriocarcinoma cell; Placenta growth factor; Soluble vascular endothelial growth factor receptor 1; Vascular endothelial growth factor

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CHORIOCARCINOMA; CHORION VILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS DEATH; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PLACENTA DEVELOPMENT; PLACENTA FUNCTION; PROTEIN SECRETION; RECURRENT ABORTION; TROPHOBLAST;

ABORTION, HABITUAL; ADULT; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CELL LINE, TUMOR; CHORIOCARCINOMA; DOWN-REGULATION; FEMALE; HUMANS; PREGNANCY PROTEINS; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS; YOUNG ADULT;

EID: 80052716137     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01490.x     Document Type: Article

References (28)

1. Aoki K, Dudkiewicz AB, Matsuura E, Novotny M, Kaberlein G, Gleicher N. Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: Correlation with conventional antiphospholipid antibody detection systems. Am J Obstet Gynecol 1995; 172: 926-931.
2. Yamamoto T, Yoshimura S, Geshi Y et al. Measurement of antiphospholipid antibody by ELISA using purified beta 2-glycoprotein I in preeclampsia. Clin Exp Immunol 1993; 94: 196-200. (Pubitemid 23308388)
3. De Groot PG, Derksen RH. Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost 2005; 3: 1854-1860. (Pubitemid 41716572)
4. Pierangeli SS, Espinola RG, Liu X, Harris EN. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res 2001; 88: 245-250. (Pubitemid 32147315)
5. Del Pana N, Guidali L, Spatola L et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: Beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995; 13: 179-185.
6. Atsumi T, Khamashta MA, Amengual O, Hughes GR. Up-regulated tissue factor expression in antiphospholipid syndrome. Thromb Haemost 1997; 77: 222-223.
7. Cho CS, Cho ML, Chen PP et al. Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells. J Immunol 2002; 168: 4209-4215. (Pubitemid 34298430)
8. Satta N, Dunoyer-Geindre S, Reber G et al. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 2007; 109: 1507-1514. (Pubitemid 46239583)
9. Mulla MJ, Brosens JJ, Chamley LW et al. Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. Am J Reprod Immunol 2009; 62: 96-111.
10. Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Ann Rev Med 2008; 59: 61-78. (Pubitemid 351287924)
11. Torry DS, Ahn H, Barnes EL, Torry RJ. Placenta growth factor: Potential role in pregnancy. Am J Reprod Immunol 1999; 41: 79-85. (Pubitemid 29108234)
12. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991; 88: 9267-9271. (Pubitemid 21915612)
13. Athanassiades A, Lala PK. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 1998; 19: 465-473. (Pubitemid 28429999)
14. Hasegawa I, Takakuwa K, Adachi S, Kanazawa K. Cytotoxic antibody against trophoblast and lymphocytes present in pregnancy with intrauterine fetal growth retardation and its relation to anti-phospholipid antibody. J Reprod Immunol 1990; 17: 127-139. (Pubitemid 20101935)
15. Di Simone N, Meroni PL, de Papa N et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2- glycoprotein I. Arthritis Rheum 2000; 43: 140-150. (Pubitemid 30368223)
16. Cuadrado MJ, López-Pedrera C, Khamashta MA, et al. Thrombosis in primary antiphospholipid syndrome: A pivotal role for monocyte tissue factor expression. Arthritis Rheum 1997; 40: 834-841.
17. Izumi T, Pound ML, Su Z, Iverson GM, Ortel TL. Antibeta( 2)-glycoprotein I antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein I to phospholipids. Thromb Haemost 2002; 88: 620-626. (Pubitemid 35174004)
18. Carreras LO, Vermylen JG. 'Lupus' anticoagulant and thrombosis - Possible role of inhibition of prostacyclin formation. Thromb Haemost 1982; 48: 38-40. (Pubitemid 12059118)
19. Dudley DJ, Mitchell MD, Branch DW. Pathophysiology of antiphospholipid antibodies: Absence of prostaglandinmediated effects on cultured endothelium. Am J Obstet Gynecol 1990; 162: 953-958; discussion 958-959.
20. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS. Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997; 56: 50-58. (Pubitemid 27024161)
21. Rand JH, Wu XX, Guller S, Scher J, Andree HA, Lockwood CJ. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 1997; 177: 918-923. (Pubitemid 27516067)
22. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188: 177-182. (Pubitemid 36135616)
23. Holers VM, Girardi G, Mo L et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 195: 211-220. (Pubitemid 34461265)
24. Girardi G, Berman J, Redecha P et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003; 112: 1644-1654. (Pubitemid 38063722)
25. Berman J, Girardi G, Salmon JE. TNF-alpha is a critical and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J Immunol 2005; 174: 485-490. (Pubitemid 40007438)
26. Sasaki S, Murase T, Kuno S, Yamamoto T. Changes of complement in recurrent abortion and pregnancy loss with antiphospholipid antibody positive. Nihon Rinsho Meneki Gakkai Kaishi 2006; 29: 372-377.
27. Loke YW. Experimenting with human extravillous trophoblast: A personal view. Am J Reprod Immunol 1990; 24: 22-28.
28. Sorice M, Longo A, Capozzi A et al. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum 2007; 56: 2687-2697. (Pubitemid 47237287)